In cancer patients affected by insulin resistance, the increase in circulating levels of insulin is combined with the frequent overexpression of the insulin receptor in cancer cells, resulting in the abnormal stimulation of non-metabolic effects of the IR, such as cell survival, proliferation, and migration [31]. This evidence concerns the gene INSR and cancer.